Tag: ANDA
Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.
The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It slashed drug costs by 90% for most prescriptions-but loopholes now threaten its success.
view morerecent posts
Find the FDA's official list of authorized generics-drugs made by brand companies but sold without the brand name. Learn where to access it, how to interpret it, and why it's not always easy to buy these lower-cost options.
Published ON: 1 DecThe FDA issues warning letters to manufacturers who violate safety and labeling laws. These letters are the first step in enforcement that can lead to recalls, fines, or criminal charges. Learn how the agency targets non-compliant companies and what you must do to avoid serious consequences.
Published ON: 1 DecLithium carbonate generics require strict serum level monitoring due to their narrow therapeutic index. Learn how brand switches, dosing, age, and kidney function affect safety and effectiveness in bipolar disorder treatment.
Published ON: 12 DecManufacturers fix quality problems by finding root causes, not just symptoms. Learn how CAPA systems, root cause analysis, and verification steps reduce defects, ensure compliance, and prevent recurrence in regulated industries.
Published ON: 5 DecHBV reactivation can strike silently during chemotherapy or biologic therapy, causing liver failure. Learn who's at risk, which drugs trigger it, and how simple screening and antiviral prophylaxis can save lives.
Published ON: 18 Dec